Kazunari Murakami

8.8k total citations · 2 hit papers
254 papers, 5.5k citations indexed

About

Kazunari Murakami is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Gastroenterology. According to data from OpenAlex, Kazunari Murakami has authored 254 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 197 papers in Surgery, 100 papers in Pulmonary and Respiratory Medicine and 62 papers in Gastroenterology. Recurrent topics in Kazunari Murakami's work include Helicobacter pylori-related gastroenterology studies (133 papers), Gastric Cancer Management and Outcomes (71 papers) and Gastroesophageal reflux and treatments (46 papers). Kazunari Murakami is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (133 papers), Gastric Cancer Management and Outcomes (71 papers) and Gastroesophageal reflux and treatments (46 papers). Kazunari Murakami collaborates with scholars based in Japan, United States and Vietnam. Kazunari Murakami's co-authors include Toshio Fujioka, Masaaki Kodama, Tadayoshi Okimoto, Mototsugu Kato, Masahiro Asaka, Ryugo Sato, Masaru Nasu, Kazuhiro Mizukami, Naomi Uemura and Seiji Shiota and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Kazunari Murakami

234 papers receiving 5.4k citations

Hit Papers

2 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study

2016 319 citations Kazunari Murakami et al. profile →
Guidelines for the management of Helicobacter pylori infection in Japan: 2016 Revised Edition

2019 223 citations Mototsugu Kato, Kiichi Satoh et al. Helicobacter profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kazunari Murakami Japan	39	4.2k	2.3k	1.7k	724	661	254	5.5k
Young Soo Park South Korea	41	3.5k 0.8×	2.2k 1.0×	1.5k 0.9×	296 0.4×	615 0.9×	281	5.7k
Kwong Ming Fock Singapore	34	3.0k 0.7×	1.6k 0.7×	1.3k 0.8×	530 0.7×	316 0.5×	122	4.5k
Theodore Rokkas Greece	32	6.4k 1.5×	2.6k 1.1×	2.7k 1.6×	765 1.1×	1.5k 2.2×	86	7.3k
Ping‐I Hsu Taiwan	38	2.9k 0.7×	1.1k 0.5×	1.4k 0.8×	527 0.7×	574 0.9×	145	4.3k
Rocco Maurizio Zagari Italy	30	3.0k 0.7×	1.4k 0.6×	1.5k 0.9×	338 0.5×	372 0.6×	96	3.9k
Hartley Cohen United States	30	3.2k 0.7×	1.4k 0.6×	953 0.6×	707 1.0×	495 0.7×	56	4.4k
Naomi Uemura Japan	37	8.7k 2.1×	4.8k 2.1×	3.4k 2.0×	1.2k 1.7×	1.0k 1.5×	190	10.8k
Michio Yamakido Japan	36	3.7k 0.9×	3.3k 1.4×	742 0.4×	1.1k 1.5×	397 0.6×	173	8.1k
K. C. Lai Hong Kong	30	2.9k 0.7×	1.5k 0.6×	1.5k 0.9×	259 0.4×	220 0.3×	59	3.9k
A T Axon United Kingdom	40	3.2k 0.7×	1.3k 0.6×	856 0.5×	646 0.9×	201 0.3×	111	4.9k

Countries citing papers authored by Kazunari Murakami

Since Specialization

Citations

This map shows the geographic impact of Kazunari Murakami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazunari Murakami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazunari Murakami more than expected).

Fields of papers citing papers by Kazunari Murakami

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazunari Murakami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazunari Murakami. The network helps show where Kazunari Murakami may publish in the future.

Co-authorship network of co-authors of Kazunari Murakami

This figure shows the co-authorship network connecting the top 25 collaborators of Kazunari Murakami. A scholar is included among the top collaborators of Kazunari Murakami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazunari Murakami. Kazunari Murakami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tanaka, Ryota, Hiroshi Abe, Tomoko Saito, et al.. (2025). Sensitive quantification of free lenvatinib using ultra-high performance liquid chromatography coupled to tandem mass spectrometry and the clinical significance of measuring free lenvatinib concentration. Clinica Chimica Acta. 569. 120188–120188.

Kodama, Masaaki, Osamu Handa, Mitsushige Sugimoto, et al.. (2025). Endoscopic risk factors to inform early detection of gastric cancer after Helicobacter pylori eradication: Meta‐analysis and systematic review. DEN Open. 5(1). e70086–e70086.

Sonoda, Akira, Yoko Kudo, Kanako Ito, et al.. (2024). Daikenchuto, a Japanese herbal medicine, ameliorates experimental colitis in a murine model by inducing secretory leukocyte protease inhibitor and modulating the gut microbiota. Frontiers in Immunology. 15. 1457562–1457562. 6 indexed citations

Hirashita, Teijiro, Kumiko Sakai, Masahiro Kawamura, et al.. (2023). Glucose metabolic upregulation via phosphorylation of S6 ribosomal protein affects tumor progression in distal cholangiocarcinoma. BMC Gastroenterology. 23(1). 157–157. 4 indexed citations

Mizukami, Kazuhiro, Ryota Sagami, Takashi Abe, et al.. (2023). Usefulness of AI-Equipped Endoscopy for Detecting Colorectal Adenoma during Colonoscopy Screening: Confirm That Colon Neoplasm Finely Can Be Identified by AI without Overlooking Study (Confidential Study). Journal of Clinical Medicine. 12(19). 6332–6332.

Okimoto, Tadayoshi, Takashi Ando, Makoto Sasaki, et al.. (2023). Antimicrobial‐resistant Helicobacter pylori in Japan: Report of nationwide surveillance for 2018–2020. Helicobacter. 29(1). e13028–e13028. 4 indexed citations

Sagami, Ryota, Kazuhiro Mizukami, Kazuhisa Okamoto, et al.. (2023). Experience-Related Factors in the Success of Beginner Endoscopic Ultrasound-Guided Biliary Drainage: A Multicenter Study. Journal of Clinical Medicine. 12(6). 2393–2393. 2 indexed citations

Mizukami, Kazuhiro, et al.. (2023). GM‐CSF‐producing CCR2⁺CCR6⁺ Th17 cells are pathogenic in dextran sodium sulfate‐induced colitis model in mice. Genes to Cells. 28(4). 267–276. 5 indexed citations

Kubo, Shuichi, Akinori Tokunaga, Hiroaki Nabeka, et al.. (2021). Inhibition of low-density lipoprotein uptake by Helicobacter pylori virulence factor CagA. Biochemical and Biophysical Research Communications. 556. 192–198. 11 indexed citations

10.

Gotoh, Koro, Yoko Kudo, Mie Arakawa, et al.. (2020). α‐Tocopherol suppresses hepatic steatosis by increasing CPT‐1 expression in a mouse model of diet‐induced nonalcoholic fatty liver disease. Obesity Science & Practice. 7(1). 91–99. 9 indexed citations

11.

Fukuda, Masahide, Hirohito Ishigaki, Hiromitsu Ban, et al.. (2018). No transformation of a fundic gland polyp with dysplasia into invasive carcinoma after 14 years of follow‐up in a proton pump inhibitor‐treated patient: A case report. Pathology International. 68(12). 706–711. 11 indexed citations

12.

Satoh, Kiichi, Junji Yoshino, Taiji Akamatsu, et al.. (2016). Evidence-based clinical practice guidelines for peptic ulcer disease 2015. Journal of Gastroenterology. 51(3). 177–194. 104 indexed citations

13.

Saito, Tomoko, Junji Kurashige, Sho Nambara, et al.. (2015). A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer. Annals of Surgical Oncology. 22(S3). 915–922. 87 indexed citations

14.

Naito, Toshio, Kenji Kanazawa, Hiroyuki Morita, et al.. (2013). Diagnostic workup for fever of unknown origin: a multicenter collaborative retrospective study. BMJ Open. 3(12). e003971–e003971. 44 indexed citations

15.

Kuroda, Akiko, Yoshiyuki Tsukamoto, Lam Tung Nguyen, et al.. (2011). Genomic Profiling of Submucosal-Invasive Gastric Cancer by Array-Based Comparative Genomic Hybridization. PLoS ONE. 6(7). e22313–e22313. 8 indexed citations

16.

Murakami, Kazunari, Takashi Abe, Kazuhiro Mizukami, et al.. (2009). Evaluation of esophageal function in patients with gastroesophageal reflux disease using transnasal endoscopy. Journal of Gastroenterology and Hepatology. 24(10). 1677–1682. 7 indexed citations

17.

Murakami, Kazunari, Reo Sato, Tadayoshi Okimoto, et al.. (2002). Eradication rates of clarithromycin‐resistant Helicobacter pylori using either rabeprazole or lansoprazole plus amoxicillin and clarithromycin. Alimentary Pharmacology & Therapeutics. 16(11). 1933–1938. 71 indexed citations

18.

Murakami, Kazunari, et al.. (1997). Helicobacter pylori infection accelerates human gastric mucosal cell proliferation. Journal of Gastroenterology. 32(2). 184–188. 33 indexed citations

19.

Murakami, Kazunari, Masanori Kawasaki, Shoji Honda, et al.. (1993). An autoptic case of solid and cystic tumor in a pancreas divisum. Acta gastro-enterologica belgica. 35(10). 2502. 1 indexed citations

20.

Sairenji, Motonori, Katsuo Suzuki, Kazunari Murakami, et al.. (1987). Transforming growth factor activity in pleural and peritoneal effusions from cancer and non-cancer patients.. PubMed. 78(8). 814–8. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact